Radiofrequency Echographic Multi-Spectrometry (REMS) is an advanced, non-invasive technology that assesses bone health by measuring both bone mineral density (BMD) and microarchitecture. Unlike traditional methods like DXA, which only focus on bone density, REMS provides a more comprehensive evaluation of bone strength by analyzing the internal structure of bones. This makes REMS particularly useful for diagnosing osteoporosis and predicting fractures, especially in patients who may have normal or elevated BMD but still face a higher fracture risk due to changes in bone quality.

REMS operates using ultrasound waves to gather data from bones, offering a radiation-free alternative that can be used for frequent monitoring. It is highly portable and easy to use, making it ideal for clinical settings and at-home assessments. By combining the ability to assess both bone density and quality, REMS enables more accurate diagnoses and better-informed treatment decisions, ultimately helping to prevent fractures and improve patient outcomes in those at risk for osteoporosis.